Zepp Health has acquired Wild.AI to enhance its offerings for female athletes, tapping into an underserved segment of the wearable technology market.
Information on the Target
Zepp Health, recognized as the parent company of the Amazfit brand, has recently captured attention with its strategic growth initiatives. Following its first quarter of positive year-over-year revenue growth since Q2 2021, the company reported a substantial 46% increase, achieving $59.4 million in revenue for Q2 2025. To bolster its market presence in the realm of premium wearables and AI-powered operating systems, Zepp Health has acquired the core assets and intellectual property of Wild.AI, a leading platform in women’s wellness. Wild.AI specializes in AI-driven hormone-informed coaching, tracking, and adaptive training tools tailored to meet the unique physiological needs of female athletes.
This acquisition marks a significant strategic pivot for Zepp Health, as it seeks to penetrate the underrepresented segment of female athletes within the global wearable technology market, valued at over $90 billion. By integrating Wild.AI’s innovative solutions, Zepp aims to enhance its offering of athlete-centric products like the Helio Strap and Balance 2, ultimately enriching the user experience and driving engagement.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
The wearable technology industry in China has experienced rapid growth, driven by increasing health awareness and the rising demand for fitness-oriented devices. As the market matures, there is a noticeable trend towards personal
Similar Deals
Zepp Health
invested in
Wild.AI
in 2025
in a Other deal
Disclosed details
Revenue: $59M